SPOTLIGHT: Novartis asthma drug gets OK from NICE

The UK's National Institute for Clinical Excellence has opened the gate for Novartis' Xolair to be used as an add-on treatment for severe allergic asthma in adults and adolescents. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.